Saneca buys Europe's only independent, US FDA approved Beta-lactams plant
API firm Saneca Pharmaceuticals has acquired struggling drug formulator Suir Pharma Ireland in a deal with former owner Mutares AG.
Archives for June 24, 2015
Parexel to lay off 850 amid restructuring
Massachusetts-based CRO Parexel is eliminating 850 positions, which it expects will cost the company $30m to $40m in employee separation benefits.
Trial data: charity hits back at CRO’s anti-transparency bid
Charity Sense About Science is attempting to intervene in a UK CRO’s legal action against trial transparency.
Google unveils new wristband to collect trial participant data
Google’s life sciences group is developing a wristband dedicated exclusively to tracking clinical trial participants’ vital signs and other data.
UK scientists discover key poppy alkaloid production enzyme
GSK and UK academics claim a newly identified enzyme is the missing link in the mechanism poppies use to make painkilling alkaloids like morphine and codeine and the anticancer compound noscapine.
CTTI offers range of QbD recommendations for clinical trials
The Clinical Trials Transformation Initiative, a public-private partnership between Duke University and the FDA, has created a list of four recommendations related to quality by design (QbD) for clinical trials.
Huntingdon Life Sciences unveils new name post-Harlan integration
Preclinical CRO Huntingdon Life Sciences has announced a new name, which it changed to mark the integration of Harlan Laboratories.
Thermo Fisher will pay £256m for Alfa Aesar
Thermo Fisher Scientific has anncouned plans to buy research chemicals firm Alfa Aesar from Johnson Matthey for £256m ($405m).
‘Record-breaking’ 2015 will see surge in pharma acquisitions
Demand for CNS assets will help break records for pharma M&As in 2015, Neel Patel, VP of inVentiv Health consultancy Campbell Alliance, tells in-Pharmatechnologist.com.